All updated as on -
In 2022, the market for single-use bioprocessing was estimated to be worth USD 23,433.8 million. From 2023 to 2030, it is expected to increase at a CAGR of 17.24%. Single-use bioprocessing technology is becoming more popular as a result of rising biopharmaceutical demand over the past several years and rising funding for the research and production of biologics such monoclonal antibodies, vaccines, recombinant proteins, and others. The adoption of single-use systems in the bioprocessing industry has also been aided by benefits related to their use, such as the large decrease in costs and time needed for operations and facility building.
For the research and production of pharmaceutical goods like vaccines, monoclonal antibodies (mAbs), customized medicine, and others, single-use bioprocessing uses disposable technologies. During the creation of several biopharmaceuticals and drug development phases, the use of single-use bioprocessing products has increased significantly. This innovation has made medication manufacturing more efficient, straightforward, and affordable both upstream and downstream. The market for single-use bioprocessing is expected to develop as a result of factors such as the rise in disposable technology adoption, the rising need for biopharmaceuticals, the reduced risk of product cross-contamination associated with SUB technologies, and the need for less floor space. Aspects including extractability and leachability problems and strict rules governing the use of disposable systems in the biopharmaceutical industry, however, restrain market expansion.
Key industry stakeholders now have new growth potential thanks to the COVID-19 pandemic. Important businesses in the biopharmaceutical industry can take advantage of the opportunity by scaling up their production facilities with the addition of single-use bioprocessing equipment and increasing the range of COVID-19-related products they offer. The development and production of COVID-19 vaccines are being aggressively pursued by a sizable number of biopharmaceutical companies. These initiatives heavily rely on single-use technologies since they are adaptable, economical, and less likely to cause cross-contamination.
According to the UN's Ageing Population Highlights, 727 million people worldwide were predicted to be 65 years of age or older in 2020; by 2050, this number is projected to quadruple to 1.5 billion people. The demand for biopharmaceuticals is anticipated to rise as the senior population grows across key markets since the aged are more sensitive to chronic illnesses and diseases. Companies increasingly favor single-use bioprocessing systems to meet the rising demand for biopharmaceuticals because they improve process efficiency and cut costs associated with labor-intensive procedures like cleaning, sterilization, and maintenance of steel-based bioreactor systems. A wide range of biopharmaceutical applications, such as filtration, mixing, purification, upstream expression, storage, and separation, use single-use bioprocessing technology. Therefore, the single use bioprocessing business is expanding primarily as a result of the rising demand for biopharmaceuticals.
There are currently no clear rules or guidelines governing the contamination of single-use bioprocessing systems by extractables and leachables. However, the Bio-Process Systems Alliance (BPSA) has released a comprehensive set of tests that can be carried out for single-use systems. Under demanding laboratory conditions, extractables can be extracted from source materials using the proper solvents. Leachables, on the other hand, are substances that seep into drug goods from packaging, closures, and manufacturing elements. As a result, leachables are a subset of extractables. These products that are extractable and leachable are undesirable. Single-use bioprocessing goods frequently experience contamination from the container due to leachables because they are constructed of processed plastic materials. In light of their possible effects on product quality and patient health, considerable concerns regarding extractables and leachables resulting from the components of single-use bioprocessing systems may restrain market expansion.
This study analyzes the market size for single-use bioprocessing by product, application, technique, end user, and geographic region. The market is segmented by product into bioreactors, depth filters, disposable filter cartridges, tangential-flow filtration devices, media bags and containers, mixing systems, tubing assemblies, sampling systems, and others. The market is segmented by application into the manufacturing of monoclonal antibodies, vaccines, plant cell culture, patient-specific cell treatments, and others. The market is divided into filtration, storage, cell culture, mixing, and purification according to method. The market is segmented into biopharmaceutical producers, life science R&D firms and university research centers, and contract research organizations & producers based on the end user. It is examined across North America, Europe, Asia-Pacific, and LAMEA based on region.
Report Coverage
Global Single-Use Bioprocessing Products research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Single-Use Bioprocessing Products report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Single-Use Bioprocessing Products competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Single-Use Bioprocessing Products market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Single-Use Bioprocessing Products market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Single-Use Bioprocessing Products market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Sartorius Stedim Biotech S.A, Danaher Corporation, Eppendorf AG, Thermo Fisher Scienctific, 3M Company, Getinge, PBS Biotech, Inc. , Corning Inc., Merck & Co. Inc., Cesco Bioengineering Co. Ltd., Avantor, Inc., Boehringer Ingelheim International GmbH, Lonza, Infors AG, Entegris, Inc., Kuhner AG, Meissner Filtration Products, Inc.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Single-Use Bioprocessing Products market based on the below-mentioned segments:
Global Single-Use Bioprocessing Products Market, By Product
Media Bags And Containers
Mixing Systems
Tubing Assemblies
Sampling Systems
Others
Tangential-Flow Filtration Devices
Depth Filters
Bioreactors
Disposable Filter Cartridges
Global Single-Use Bioprocessing Products market, By Application
Monoclonal Antibody Production
Plant Cell Cultivation
Patient Specific Cell Therapies
Others
Vaccine Production
Global Single-Use Bioprocessing Products Market, By End User
Biopharmaceutical Manufacturers
Contract Research Organization and Manufacturers
Life Science R and D Companies and Academic Research
Global Single-Use Bioprocessing Products market, Regional Analysis
For the research and production of pharmaceutical goods like vaccines, monoclonal antibodies (mAbs), customized medicine, and others, single-use bioprocessing uses disposable technologies. During the creation of several biopharmaceuticals and drug development phases, the use of single-use bioprocessing products has increased significantly. This innovation has made medication manufacturing more efficient, straightforward, and affordable both upstream and downstream. The market for single-use bioprocessing is expected to develop as a result of factors such as the rise in disposable technology adoption, the rising need for biopharmaceuticals, the reduced risk of product cross-contamination associated with SUB technologies, and the need for less floor space. Aspects including extractability and leachability problems and strict rules governing the use of disposable systems in the biopharmaceutical industry, however, restrain market expansion.
Key industry stakeholders now have new growth potential thanks to the COVID-19 pandemic. Important businesses in the biopharmaceutical industry can take advantage of the opportunity by scaling up their production facilities with the addition of single-use bioprocessing equipment and increasing the range of COVID-19-related products they offer. The development and production of COVID-19 vaccines are being aggressively pursued by a sizable number of biopharmaceutical companies. These initiatives heavily rely on single-use technologies since they are adaptable, economical, and less likely to cause cross-contamination.
According to the UN's Ageing Population Highlights, 727 million people worldwide were predicted to be 65 years of age or older in 2020; by 2050, this number is projected to quadruple to 1.5 billion people. The demand for biopharmaceuticals is anticipated to rise as the senior population grows across key markets since the aged are more sensitive to chronic illnesses and diseases. Companies increasingly favor single-use bioprocessing systems to meet the rising demand for biopharmaceuticals because they improve process efficiency and cut costs associated with labor-intensive procedures like cleaning, sterilization, and maintenance of steel-based bioreactor systems. A wide range of biopharmaceutical applications, such as filtration, mixing, purification, upstream expression, storage, and separation, use single-use bioprocessing technology. Therefore, the single use bioprocessing business is expanding primarily as a result of the rising demand for biopharmaceuticals.
There are currently no clear rules or guidelines governing the contamination of single-use bioprocessing systems by extractables and leachables. However, the Bio-Process Systems Alliance (BPSA) has released a comprehensive set of tests that can be carried out for single-use systems. Under demanding laboratory conditions, extractables can be extracted from source materials using the proper solvents. Leachables, on the other hand, are substances that seep into drug goods from packaging, closures, and manufacturing elements. As a result, leachables are a subset of extractables. These products that are extractable and leachable are undesirable. Single-use bioprocessing goods frequently experience contamination from the container due to leachables because they are constructed of processed plastic materials. In light of their possible effects on product quality and patient health, considerable concerns regarding extractables and leachables resulting from the components of single-use bioprocessing systems may restrain market expansion.
This study analyzes the market size for single-use bioprocessing by product, application, technique, end user, and geographic region. The market is segmented by product into bioreactors, depth filters, disposable filter cartridges, tangential-flow filtration devices, media bags and containers, mixing systems, tubing assemblies, sampling systems, and others. The market is segmented by application into the manufacturing of monoclonal antibodies, vaccines, plant cell culture, patient-specific cell treatments, and others. The market is divided into filtration, storage, cell culture, mixing, and purification according to method. The market is segmented into biopharmaceutical producers, life science R&D firms and university research centers, and contract research organizations & producers based on the end user. It is examined across North America, Europe, Asia-Pacific, and LAMEA based on region.
Report Coverage
Global Single-Use Bioprocessing Products research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Single-Use Bioprocessing Products report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Single-Use Bioprocessing Products competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Single-Use Bioprocessing Products market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Sartorius Stedim Biotech S.A, Danaher Corporation, Eppendorf AG, Thermo Fisher Scienctific, 3M Company, Getinge, PBS Biotech, Inc. , Corning Inc., Merck & Co. Inc., Cesco Bioengineering Co. Ltd., Avantor, Inc., Boehringer Ingelheim International GmbH, Lonza, Infors AG, Entegris, Inc., Kuhner AG, Meissner Filtration Products, Inc. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Single-Use Bioprocessing Products Market from 2021 to 2030.
- Market Forecast for Single-Use Bioprocessing Products Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Single-Use Bioprocessing Products competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Single-Use Bioprocessing Products
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Single-Use Bioprocessing Products market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Single-Use Bioprocessing Products market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Sartorius Stedim Biotech S.A, Danaher Corporation, Eppendorf AG, Thermo Fisher Scienctific, 3M Company, Getinge, PBS Biotech, Inc. , Corning Inc., Merck & Co. Inc., Cesco Bioengineering Co. Ltd., Avantor, Inc., Boehringer Ingelheim International GmbH, Lonza, Infors AG, Entegris, Inc., Kuhner AG, Meissner Filtration Products, Inc.
Primary Target Market
- Market Players of Single-Use Bioprocessing Products
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Single-Use Bioprocessing Products market based on the below-mentioned segments:
Global Single-Use Bioprocessing Products Market, By Product
Media Bags And Containers
Mixing Systems
Tubing Assemblies
Sampling Systems
Others
Tangential-Flow Filtration Devices
Depth Filters
Bioreactors
Disposable Filter Cartridges
Global Single-Use Bioprocessing Products market, By Application
Monoclonal Antibody Production
Plant Cell Cultivation
Patient Specific Cell Therapies
Others
Vaccine Production
Global Single-Use Bioprocessing Products Market, By End User
Biopharmaceutical Manufacturers
Contract Research Organization and Manufacturers
Life Science R and D Companies and Academic Research
Global Single-Use Bioprocessing Products market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive single use bioprocessing products market market research and competitor analysis for your business to help you develop more profound insights into the single use bioprocessing products market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the single use bioprocessing products market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.